DrugEBIlity statistics

info info

Citations per year


Popular tool citations

chevron_left Structure-based virtual screening chevron_right

Tool usage distribution map

Tool usage distribution map
info info

Associated diseases

Associated diseases
Want to access the full stats & trends on this tool?

DrugEBIlity specifications


Unique identifier OMICS_19740
Name DrugEBIlity
Software type Application/Script
Interface Web user interface
Restrictions to use None
License Creative Commons - Attribution Share-Alike 3.0 Unported license
Computer skills Basic
Stability Stable
Maintained Yes

Additional information


DrugEBIlity citations


Guanylate binding protein 1 is a potential new therapeutic target for triple negative breast cancer

PMCID: 5688804
PMID: 29115931
DOI: 10.1186/s12885-017-3726-2

[…] 42 of which presented structure-based druggability (fig. ), as they showed potential small molecule binding pockets in an analysis based on the chembl strudel https://www.ebi.ac.uk/chembl/drugebility/) (drugebility) methodology. among these genes, 10 exhibited ligand-based druggability scores falling within the 75% percentile or above defined for all of the proteins in the platform […]


Druggability Analysis and Structural Classification of Bromodomain Acetyl lysine Binding Sites

PMCID: 3441041
PMID: 22788793
DOI: 10.1021/jm300346w

[…] that may not be representative of the family as a whole., many structure-based druggability prediction methods have been published in recent years, these include dlid, dogsitescorer, the ebi’s drugebility, drugpred, fpocket, mappod, screen, and sitemap. reviews by hajduk et al. and fauman et al. cover a number of these methods and some of the challenges in computational druggability […]

Want to access the full list of citations?

DrugEBIlity reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review DrugEBIlity